influenza
respiratori
viral
infect
common
type
acut
respiratori
infect
viral
infect
predispos
patient
secondari
bacteri
infect
often
sever
clinic
cours
mechan
underli
postvir
bacteri
infect
complex
includ
multifactori
process
mediat
interact
virus
bacteria
host
immun
system
studi
past
year
demonstr
uniqu
microbi
commun
resid
mucos
surfac
gastrointestin
tract
respiratori
tract
direct
indirect
effect
host
defens
viral
infect
addit
antivir
immun
respons
induc
acut
respiratori
infect
influenza
associ
chang
microbi
composit
function
dysbiosi
respiratori
gastrointestin
tract
turn
may
alter
subsequ
immun
function
secondari
bacteri
infect
alter
dynam
intermicrobi
interact
therebi
enhanc
prolifer
potenti
pathogen
bacteri
speci
review
summar
literatur
interact
host
microbi
commun
host
defens
influenza
acut
respiratori
viral
infect
disrupt
interact
therebi
contribut
pathogenesi
secondari
bacteri
infect
influenza
bacteri
pneumonia
lead
caus
morbid
mortal
infecti
diseas
worldwid
influenza
respiratori
viral
infect
predispos
patient
secondari
bacteri
superinfect
frequent
associ
sever
clinic
cours
estim
socal
spanish
flu
pandem
influenza
viru
result
million
death
mani
caus
bacteri
superinfect
lead
secondari
pneumonia
even
antibiot
era
half
patient
sever
infect
pandem
bacteri
complic
bacteri
coinfect
also
detect
case
pandem
high
mortal
rate
despit
administr
appropri
antibiot
thu
evid
better
understand
pathogenesi
secondari
bacteri
pneumonia
follow
viral
infect
need
order
make
therapeut
stride
devast
complic
mechan
postvir
bacteri
infect
complex
compris
multifactori
process
mediat
interact
virus
bacteria
host
immun
system
pathogenesi
superinfect
attribut
direct
mucosalepitheli
damag
influenza
viru
increas
bacteri
colon
upper
lower
respiratori
tract
urt
lrt
respect
dysregul
immun
respons
lead
increas
suscept
secondari
bacteri
infect
howev
emerg
evid
suggest
microbi
commun
resid
mucos
surfac
like
shape
rigor
immun
respons
shape
ecolog
relationship
host
pathogen
past
year
intens
interest
focus
examin
microbi
commun
inhabit
bodieswhich
consid
separ
organ
system
given
sheer
physic
bulk
number
gene
metabol
activitiesgovern
balanc
health
suscept
diseas
includ
infect
rais
possibl
disrupt
normal
microbi
commun
acut
viral
infect
might
contribut
develop
postvir
bacteri
pneumonia
recent
develop
cultureindepend
method
microbi
identif
enabl
studi
microbi
commun
mucos
surfac
human
bodi
refer
microbiota
microbi
commun
mammalian
host
divers
compris
bacteri
virus
archaea
parasit
fungi
human
microbiom
project
hmp
similar
largescal
sequenc
project
worldwid
character
distinct
microbi
commun
adapt
uniqu
environment
nich
within
bodi
gut
skin
airway
genitourinari
tract
oral
caviti
gut
microbiom
particular
shown
play
integr
role
shape
immun
system
start
earli
life
continu
influenc
prime
natur
robust
immun
respons
throughout
one
lifetim
respiratori
tract
also
harbor
distinct
commun
microb
multipl
discret
ecolog
nich
eg
nasal
caviti
oropharynx
upper
airway
vari
term
temperatur
ph
oxygen
tension
mucu
product
factor
effect
viral
infect
gut
respiratori
microbiom
recent
undergon
examin
surprisingli
influenza
infect
found
result
signific
chang
gut
microbiom
despit
lack
detect
virion
gi
tract
comparison
effect
viral
infect
respiratori
microbiom
appear
rel
modest
detect
effect
alter
risk
secondari
bacteri
pneumonia
studi
potenti
mechan
chang
might
modul
suscept
secondari
bacteri
infect
includ
alter
natur
magnitud
immun
respons
host
microbiom
host
effect
facilit
growth
pathogen
absenc
normal
commens
intermicrobi
effect
articl
review
current
understand
alter
microbiom
follow
viral
infect
might
alter
host
immun
respons
increas
suscept
secondari
bacteri
infect
although
term
microbiom
encompass
microbi
commun
current
pauciti
studi
mycobiom
fungal
microbiom
virom
viral
microbiom
affect
host
defens
respiratori
infect
viceversa
thu
review
focu
bacteri
microbiom
literatur
nich
bodi
gut
microbi
commun
intens
studi
public
date
virom
mycobiom
fungi
also
analyz
bulk
literatur
focus
bacteri
compon
microbiom
thu
understand
relat
gut
microbiom
host
immun
pathogenesi
chronic
diseas
come
larg
studi
bacteri
commun
health
human
gut
bacteri
commun
divers
individu
harbor
trillion
bacteria
compris
differ
speci
gastrointestin
microbiota
domin
firmicut
eg
lactobacillu
bacillu
clostridium
bacteroidet
eg
bacteroid
lower
abund
proteobacteria
eg
escherichia
actinobacteria
eg
bifidobacterium
wildliv
mice
exhibit
divers
microbiom
signific
abund
proteobacteria
well
firmicut
bacteroidet
gut
microbiom
addit
metabol
function
host
play
integr
role
develop
instruct
prime
immun
system
germfre
gf
mice
lack
microbiota
markedli
underdevelop
gutassoci
lymphoid
tissu
decreas
number
smallers
peyer
patch
mesenter
lymph
node
defect
antibodi
product
compar
specif
pathogen
free
spf
mice
surprisingli
germfre
anim
exhibit
increas
suscept
multipl
type
infect
includ
virus
bacteria
parasit
howev
compar
freeliv
mice
laboratori
anim
expos
gut
flora
wild
mice
spf
anim
limit
microbi
commun
also
suscept
inflammatori
diseas
reduc
immun
repertoir
includ
deficit
memori
respons
although
extens
discuss
healthi
gut
microbiom
impact
host
immun
beyond
scope
review
highlight
import
aspect
intestin
bacteri
commun
microbiom
maintain
healthi
host
immun
environ
first
bacteri
metabolit
gener
gut
commens
contribut
mainten
intact
epitheli
integr
regulatori
tcell
develop
rel
antiinflammatori
immun
state
particular
shortchain
fatti
acid
scfa
acet
propion
butyr
ferment
product
dietari
fiber
carbohydr
larg
intestin
bacteria
addit
major
energi
sourc
intestin
epitheli
cell
scfa
promot
develop
naiv
cell
regulatori
cell
induc
tolerogen
dendrit
cell
intestin
mucosa
limit
autoimm
time
microbi
metabolit
integr
promot
immun
respons
gut
pathogen
includ
induc
secret
defensin
thu
product
microbiom
metabol
integr
appropri
regul
mucos
barrier
integr
immun
homeostasi
addit
specif
member
bacteri
commun
shown
foster
proper
matur
develop
immun
system
still
area
undergo
intens
investig
one
notabl
exampl
discoveri
segment
filament
bacteria
critic
promot
intestin
mucos
iga
product
cell
induct
dysbiosi
imbal
normal
composit
microbiom
associ
varieti
chronic
diseas
mani
character
chronic
inflamm
abnorm
metabol
includ
inflammatori
bowel
diseas
cardiovascular
diseas
diabet
thu
foster
appropri
level
divers
composit
gut
microbi
commun
critic
promot
health
immun
homeostasi
health
composit
microbiom
govern
number
select
pressur
uniqu
anatom
nich
includ
temperatur
nutrient
avail
ph
oxygen
tension
local
immun
environ
shortterm
perturb
gut
microenviron
caus
ill
antibiot
usag
dietari
chang
eg
starvat
alter
gut
microbiom
subsequ
lead
transient
alter
immun
respons
thu
investig
whether
influenza
respiratori
virus
alter
gastrointestin
microbiom
could
mechanist
implic
viralmedi
suppress
antibacteri
immun
respons
although
composit
gastrointestin
microbiom
larg
influenc
dietari
pattern
respiratori
viral
infect
could
also
contribut
along
stress
induc
broadspectrum
antibiot
exposur
chronic
inflamm
use
anim
model
pulmonari
infect
influenza
respiratori
syncyti
viru
rsv
multipl
group
shown
gut
microbiom
clearli
impact
respiratori
viral
infect
despit
lack
detect
respiratori
viru
gut
murin
model
influenza
infect
investig
found
although
total
number
bacteria
gut
decreas
reduct
quantiti
segment
filament
bacteria
sfb
lactobacilluslactococcu
accompani
increas
enterobacteriacea
interestingli
although
sfb
previous
shown
induc
cell
fluinfect
mice
increas
level
number
cell
small
intestin
colon
appear
contribut
intestin
injuri
studi
antibiot
treatment
prior
influenza
infect
amelior
degre
intestin
injuri
lung
injuri
suggest
gut
dysbiosi
contribut
local
system
inflamm
group
similarli
report
increas
proteobacteria
phylum
enterobacteriacea
member
decreas
firmicut
includ
sfb
lactobacillu
lactococcu
speci
increas
bacteroidet
follow
infect
flu
rsv
administr
live
attenu
influenza
vaccin
laiv
indic
live
viral
infect
requir
chang
increas
proteobacteria
appear
mediat
type
interferon
ifn
deplet
anaerob
bacteria
also
increas
suscept
secondari
salmonella
coliti
howev
calor
restrict
also
figur
shift
mous
gut
microbiom
set
influenza
infect
acut
respiratori
viral
infect
chang
bacteri
composit
gut
microbiom
observ
despit
absenc
detect
viru
gastrointestin
compart
suggest
system
immun
signal
physiolog
chang
eg
weight
loss
still
unknown
factor
disrupt
normal
ecolog
gut
therebi
lead
dysbiosi
howev
major
studi
conduct
laboratori
anim
hous
spf
condit
remain
determin
whether
human
patient
mammalian
host
divers
baselin
gut
microbiota
ie
mice
wild
exhibit
similar
qualit
quantit
chang
result
increas
rel
abund
proteobacteria
increas
bacteroidet
firmicut
ratio
rais
possibl
decreas
oral
intak
influenza
may
contribut
chang
microbiom
also
shown
influenza
infect
alter
intestin
microbiota
composit
type
ii
ifn
produc
lungderiv
cell
recruit
intestin
thu
chang
gut
microbiom
appear
result
direct
viral
effect
system
inflammatori
signal
travel
lung
trigger
local
inflammatori
respons
gut
figur
interact
respiratori
tract
infect
gut
microbiom
bidirect
respiratori
viral
infect
chang
gut
microbiom
gut
microbiom
also
shape
adapt
immun
respons
respiratori
pathogen
mice
pretreat
antibiot
cocktail
show
increas
morbid
mortal
influenza
infect
sever
infect
associ
reduct
dendrit
cell
migrat
rate
number
local
cell
mice
given
week
oral
cours
broadspectrum
antibiot
respiratori
viral
infect
mount
attenu
antibodi
respons
incap
induc
cellmedi
respons
antigen
fewer
influenzaspecif
cell
mice
also
higher
viral
titer
lung
germfre
mice
antibiotictr
mice
also
exhibit
impair
antibodi
respons
season
influenza
vaccin
restor
oral
administr
flagel
e
coli
demonstr
depend
sens
host
microbiota
gut
microbiom
essenti
prime
innat
immun
respons
pulmonari
infect
well
viral
infect
degre
macrophag
respons
respiratori
virus
depend
presenc
gut
microb
macrophag
anim
treat
antibiot
exhibit
defect
respons
type
ii
ifn
impair
capac
limit
viral
replic
suggest
intestin
microbiota
provid
immun
stimul
establish
activ
threshold
innat
antivir
immun
respons
comparison
mice
jackson
laboratori
lack
sfb
stool
tacon
bioscienc
sfb
posit
reveal
sfbdefici
anim
increas
lung
bacteri
burden
sever
pneumonia
challeng
methicillinresist
staphylococcu
aureu
mrsa
associ
decreas
respons
lung
anoth
studi
use
broadspectrum
antibiot
treatment
follow
intranas
administr
pneumonia
mice
demonstr
microbiom
deplet
led
decreas
surviv
increas
lung
bacteri
burden
increas
system
dissemin
bacteria
antibioticpretr
anim
display
alter
cytokin
profil
lung
compar
untreat
control
follow
pneumonia
infect
includ
significantli
decreas
level
h
infect
addit
microbiotadeplet
group
alveolar
macrophag
blood
neutrophil
exhibit
decreas
phagocyt
activ
decreas
inflammatori
cytokin
product
follow
ex
vivo
stimul
tolllik
receptor
tlr
ligand
lipoteicho
acid
lta
effect
might
mediat
part
decreas
sens
mesodap
diaminopimel
acid
contain
peptidoglycan
found
gut
microbiota
previous
shown
essenti
prime
innat
immun
respons
pneumonia
thu
antibioticinduc
disrupt
normal
gut
microbi
commun
alter
multipl
aspect
normal
host
defens
acut
respiratori
pathogen
figur
collect
studi
suggest
modul
gastrointestin
tract
microbiom
play
import
role
acut
respiratori
infect
precis
microbiom
manipul
promot
appropri
immun
respons
acut
respiratori
infect
unclear
current
clinic
studi
shown
although
probiot
influenc
incid
respiratori
tract
infect
reduc
sever
symptom
durat
ill
pinpoint
member
gut
microbi
commun
essenti
proper
immun
prime
challeng
necessari
guid
microbiomebas
therapi
clostridium
orbiscinden
member
human
gut
microbiom
found
produc
desaminotyrosin
dat
metabol
flavonoid
amino
acid
antibiotictr
mice
exhibit
markedli
decreas
fecal
serum
dat
level
associ
attenu
type
ifn
respons
influenza
infect
increas
mortal
thu
identif
datproduc
microbiota
might
serv
modal
prime
type
ifn
respons
viral
infect
anoth
group
demonstr
oral
administr
lactobacillu
plantarum
enhanc
type
ifn
respons
lower
viral
titer
lung
murin
model
influenza
infect
lactobacillu
strain
known
enhanc
product
nasal
lymphocyt
upon
influenza
infect
oral
administr
probiot
cocktail
contain
lactobacillu
restor
immun
respons
enhanc
activ
signal
pathway
associ
recognit
singlestrand
rna
viru
altern
approach
administ
probiot
alter
local
metabol
environ
regul
immun
respons
recent
report
demonstr
anim
fed
high
fiber
diet
increas
gener
scfa
lead
enhanc
antivir
cell
immun
respons
attenu
neutrophilmedi
lung
injuri
influenza
infect
result
improv
surviv
thu
one
strategi
decreas
incid
postvir
bacteri
infect
limit
sever
primari
viral
infect
howev
activ
antivir
immun
respons
includ
type
type
ii
ifn
associ
increas
suscept
secondari
bacteri
pneumonia
thu
anoth
strategi
enhanc
immun
respons
common
bacteri
caus
pneumonia
one
group
recolon
antibiotictr
germfre
mice
group
cultivat
commens
bacteria
found
administr
lactobacillu
reuteri
enterococcu
faecali
lactobacillu
crispatu
clostridium
orbiscinden
strong
stimul
ie
cytosol
receptor
muramyl
dipeptid
found
cell
wall
certain
bacteria
abl
protect
bacteri
pneumonia
enhanc
gmcsf
product
whether
viralinduc
chang
gut
microbiom
associ
immun
defect
promot
secondari
bacteri
pneumonia
whether
impair
antibacteri
defens
observ
virallyinfect
host
restor
augment
certain
compon
microbiom
import
area
investig
microbiom
respiratori
tract
also
investig
context
viral
infect
role
develop
secondari
bacteri
pneumonia
follow
influenza
acut
respiratori
viral
infect
unclear
respiratori
tract
main
site
continu
contact
frontier
immunolog
wwwfrontiersinorg
figur
effect
antibiot
pretreat
immun
respons
influenza
streptococcu
pneumonia
lipoteicho
acid
lta
effect
gut
microbiom
immun
respons
respiratori
pathogen
investig
administr
oral
antibiot
gener
alter
gut
flora
follow
acut
infect
analyz
host
immun
respons
compar
nonantibioticpretr
anim
multipl
aspect
innat
adapt
immun
respons
alter
antibiot
treat
anim
includ
decreas
antibodi
product
decreas
phagocyt
activ
decreas
inflammatori
cytokin
product
innat
immun
cell
eg
alveolar
periton
macrophag
follow
ex
vivo
stimul
tlr
ligand
exogen
microb
case
gut
immun
mucos
interfac
respiratori
tract
constant
balanc
toler
commens
noninvas
microb
immun
activ
pathogen
urt
lrt
similar
microbi
commun
composit
although
microb
densiti
much
higher
former
healthi
host
sever
factor
known
influenc
airway
microbiom
composit
includ
infect
histori
age
genet
structur
lung
diseas
urt
interconnect
system
consist
anterior
nare
nasal
caviti
nasopharynx
sinus
eustachian
tube
middl
ear
caviti
oral
caviti
oropharynx
larynx
serv
distinct
nich
microbi
commun
healthi
adult
bacteria
present
nasal
caviti
typic
associ
skin
predominantli
member
actinobacteria
eg
corynebacterium
spp
propionibacterium
spp
follow
firmicut
eg
staphylococcu
spp
proteobacteria
oropharynx
contain
member
firmicut
proteobacteria
bacteroidet
includ
streptococcu
neisseria
haemophilu
lachnospira
spp
skin
oral
caviti
lineag
repres
nasopharynxeg
streptococcu
staphylococcu
corynebacterium
prevotella
limit
number
pathogen
includ
streptococcu
pneumonia
neisseria
meningitid
haemophilu
influenza
commens
bacteria
urt
healthi
individu
microbi
commun
rich
ie
total
number
bacteri
taxa
lower
lrt
urt
contrari
dogma
normal
healthi
lung
steril
environ
distinct
somewhat
dynam
lung
microbiom
identifi
use
sequenc
technolog
microaspir
serv
primari
rout
microbi
immigr
urt
lrt
major
phyla
healthi
lung
bacteroidet
firmicut
mainli
includ
prevotella
veillonella
streptococcu
individu
chronic
airway
diseas
eg
cystic
fibrosi
copd
increas
bacteri
popul
lung
differ
rel
abund
certain
speci
impair
airway
clearanc
due
intrins
extrins
factor
lead
prolifer
bacteri
speci
exploit
growth
opportun
respiratori
viral
infect
affect
divers
microbi
commun
whether
viralinduc
dysbiosi
influenc
immun
function
examin
nonetheless
bacteri
colon
urt
gener
consid
first
step
develop
invas
bacteri
infect
includ
secondari
bacteri
infect
follow
respiratori
viral
infect
bacteri
abund
speci
divers
factor
shape
immun
respons
subsequ
infect
discuss
greater
detail
respiratori
virus
enter
human
bodi
urt
common
type
acut
infect
respiratori
tract
one
possibl
mechan
influenza
viral
infect
might
predispos
infect
host
secondari
bacteri
pneumonia
alter
microbi
composit
upper
respiratori
tract
foster
enhanc
growth
pathogen
facilit
subsequ
entri
larg
bacteri
load
lrt
section
examin
recent
literatur
acut
respiratori
viral
infect
chang
urt
microbiom
given
effect
virus
enhanc
bacteri
adher
epithelium
perhap
surpris
multipl
studi
human
subject
well
anim
model
shown
viral
infect
associ
increas
colon
potenti
pathogen
bacteria
known
pathobiont
compar
analysi
use
qpcr
detect
specif
bacteria
adult
patient
without
influenza
infect
show
staphylococcu
aureu
pneumonia
h
influenza
present
infect
patient
respect
compar
uninfect
patient
experiment
vitro
model
viral
infect
increas
colon
rate
variou
bacteria
urt
includ
pneumonia
h
influenza
children
influenza
associ
increas
nasopharyng
titer
pneumonia
anim
model
similarli
confirm
viral
infect
particularli
influenza
increas
bacteri
colon
rate
urt
enhanc
risk
secondari
bacteri
infect
higher
pneumococc
colon
densiti
link
respiratori
viru
coinfect
invas
pneumococc
pneumonia
adjust
age
sex
anoth
casecontrol
studi
compar
nasopharyng
bacteria
without
pneumonia
also
found
associ
nasopharyng
load
pneumoniaebut
h
influenza
catarrhalisand
viral
coinfect
pneumonia
addit
viral
infect
potenti
may
enhanc
transmiss
bacteria
studi
mice
colon
pneumonia
infect
influenza
viru
day
pneumonia
transmiss
occur
mice
infect
influenza
block
influenzaneutr
antibodi
howev
specif
bacteria
might
gain
competit
advantag
viral
infect
univers
translat
bacteri
taxa
recent
studi
subject
without
respiratori
viral
infect
demonstr
lower
overal
bacteri
read
nasopharyng
sampl
virallyinfect
subject
compar
uninfect
control
relationship
acut
viral
infect
bacteri
colon
appear
bidirect
bacteri
carriag
ligand
increas
decreas
viral
infect
rate
therebi
posit
neg
influenc
subsequ
host
immun
respons
viral
infect
viral
replic
respiratori
tract
enhanc
exposur
pneumonia
patient
harbor
pneumonia
like
experi
subsequ
acut
respiratori
ill
episod
without
colon
addit
bacteria
present
airway
modul
host
respons
viral
infect
presenc
nasopharyng
commens
protect
mice
rsvinduc
airway
hyperrespons
rsvinfect
mice
underw
antibioticmedi
deplet
streptococcu
viridan
nasopharynx
exhibit
increas
number
inflammatori
lymphocyt
airway
hyperrespons
decreas
regulatori
cell
number
transform
growth
product
other
shown
colon
urt
aureu
drastic
reduc
influenzainduc
acut
lung
injuri
mortal
mice
recruit
cc
chemokin
receptor
type
cluster
differenti
cd
monocyt
subset
lung
induc
macrophag
phenotyp
avail
nextgener
rrna
sequenc
microbiomebas
studi
attempt
discern
global
pattern
chang
bacteri
commun
anatom
nich
viral
infect
chang
divers
divers
assess
use
varieti
indic
total
number
uniqu
speci
microbiom
ie
rich
measur
account
rich
even
rel
abund
member
commun
eg
shannon
index
result
microbiom
analys
demonstr
consist
chang
divers
compar
viral
infect
subject
healthi
control
surpris
given
variabl
subject
sampl
differ
type
sever
viral
infect
type
time
sampl
collect
analysi
methodolog
studi
increas
bacteri
divers
appear
associ
influenza
sever
french
studi
children
admit
hospit
influenza
reveal
increas
divers
nasopharyng
microflora
increas
influenza
sever
children
sever
influenza
show
decreas
rel
abund
aureu
increas
abund
prevotella
streptobacillu
porphyromona
granulicatella
veillonella
fusobacterium
haemophilu
recent
chines
studi
patient
avian
influenza
demonstr
significantli
increas
divers
oropharyng
microbiom
patient
compar
healthi
control
particularli
patient
secondari
bacteri
pneumonia
convers
french
studi
nasopharyng
sampl
south
korean
studi
oropharyng
sampl
patient
acut
respiratori
viral
infect
display
decreas
divers
indic
viral
infect
compar
healthi
control
studi
includ
subject
rang
infant
adult
year
age
limit
conclus
agerel
effect
longitudin
studi
conduct
healthi
volunt
underw
experiment
selfinnocul
rhinoviru
also
fail
demonstr
signific
chang
divers
urt
microbiom
administr
laiv
vaccin
healthi
adult
led
increas
divers
measur
follow
viral
challeng
thu
unlik
diseas
decreas
divers
consid
deleteri
host
effect
viral
infect
divers
per
se
variabl
present
consid
good
indic
risk
complic
includ
secondari
bacteri
pneumonia
microbiom
sequenc
studi
also
enabl
investig
identifi
chang
abund
among
multipl
bacteri
taxa
simultan
beyond
cultur
individu
allow
investig
determin
group
bacteria
chang
unison
viral
infect
exist
competit
one
anoth
inform
may
implic
develop
probiot
therapi
discuss
recent
metagenomicsbas
studi
franc
report
enrich
aureu
pneumonia
h
influenza
moraxella
catarrhali
klebsiella
pneumonia
nasopharyng
sampl
subject
confirm
respiratori
viral
infect
compar
healthi
control
examin
oropharyng
microbiom
pneumonia
patient
without
influenza
pandem
viral
infect
show
firmicut
includ
staphylococcu
streptococcu
spp
proteobacteria
mainli
pseudomona
amygdali
p
fluorescen
pseudomona
sp
acinetobact
baumanii
junii
significantli
enrich
patient
influenza
anoth
studi
patient
pandem
influenza
infect
reveal
predomin
phyla
upper
respiratori
tract
nasal
nasopharyng
sampl
patient
harbor
pandem
actinobacteria
firmicut
proteobacteria
although
normal
control
includ
howev
author
suggest
flu
associ
expans
proteobacteria
gener
less
abund
healthi
host
find
support
anoth
group
found
moraxella
enterobact
spp
classifi
proteobacteria
highli
repres
bacteria
nasopharyng
sampl
obtain
patient
pandem
influenza
howev
studi
demonstr
consider
intersubject
variabl
highlight
need
longitudin
studi
deciph
chang
follow
viral
infect
investig
also
sought
determin
whether
specif
virus
consist
link
enrich
certain
bacteri
taxa
nasopharyng
compart
aborigin
nonaborigin
children
australia
posit
associ
detect
hrv
pneumonia
h
influenza
moraxella
catarrhali
carriag
well
adenoviru
catarrhali
anoth
studi
examin
presenc
respiratori
virus
pcr
panel
preval
bacteri
carriag
nasopharynx
children
found
strong
posit
associ
aureu
colon
influenza
viru
moreov
pneumonia
colon
posit
associ
presenc
hrv
enterovirus
h
influenza
posit
associ
hrv
rsv
catarrhali
colon
posit
associ
coronavirus
adenovirus
rrna
sequencingbas
studi
conduct
infant
acut
rsv
hrv
respiratori
infect
report
infant
rsv
significantli
higher
abund
staphylococcu
spp
compar
hrvinfect
infant
analysi
urt
bacteri
content
healthi
asymptomat
individu
patient
influenza
viru
parainfluenza
hrv
rsv
coronaviru
adenoviru
metapneumoviru
cultureindepend
pyrosequenc
reveal
six
distinct
bacteri
profilesi
streptococcu
prevotella
veillonella
streptococcu
haemophilu
neisseria
streptococcu
moraxella
haemophilu
klebsiella
profil
howev
associ
viru
type
link
age
subject
given
mani
human
studi
crosssect
natur
remain
unclear
whether
postvir
bacteri
pneumonia
might
result
viral
infect
enhanc
bacteri
colon
acquisit
colon
bacteria
influenc
host
suscept
respiratori
viral
infect
combin
anoth
complic
factor
particularli
crosssect
studi
examin
microbiom
viral
infect
group
wellcontrol
sampl
number
rel
small
consid
number
variabl
could
affect
respiratori
tract
microbiomesuch
age
gender
oral
hygien
nosepick
habit
healthcarebas
employ
statu
smoke
statu
medic
use
exposur
small
children
etc
underli
type
viral
infect
sampl
timepoint
onset
infect
sever
infect
concomitt
antimicrobi
usag
confound
factor
may
underli
highli
variabl
sometim
discrep
observ
microbiom
studi
patient
viral
infect
clinic
studi
compar
baselin
preand
postinfect
microbiom
otherwis
healthi
individu
acut
viral
infect
due
difficulti
sampl
infect
howev
rel
studi
avail
provid
insight
dynam
stabil
bacteria
colon
pattern
time
whether
perturb
brought
acut
viral
infect
alter
pattern
healthi
children
major
phyla
among
nasopharyng
microbiota
proteobacteria
firmicut
bacteroidet
actinobacteria
fusobacteria
moraxella
haemophilu
streptococcu
flavobacteria
dolosigranulum
corynebacterium
neisseria
predomin
genera
chang
nasopharyng
microbiom
divers
observ
across
season
predomin
proteobacteria
fusobacteria
fallwint
bacteroidet
firmicut
spring
differ
independ
recent
antibiot
viral
coinfect
howev
anoth
analysi
two
nasopharyng
wash
collect
month
apart
children
adolesc
asthma
show
signific
differ
nasopharyng
microbiom
divers
across
season
although
mean
rel
abund
haemophilu
moraxella
staphylococcu
corynebacterium
vari
significantli
summer
fall
sampl
age
group
moreov
patient
oper
taxonom
unit
otu
patient
vari
significantli
time
point
investig
frequenc
season
variat
bacteri
viral
load
asymptomat
healthcar
profession
winter
summer
month
show
subject
test
winter
colon
least
one
bacteri
speci
test
posit
least
one
viru
frequent
detect
pathogen
methicillinresist
staphylococcu
aureu
mrsa
catarrhali
coronaviru
contrast
subject
test
summer
harbor
least
one
bacterium
mainli
mrsa
k
pneumonia
four
test
posit
one
viru
sever
larger
scale
surveil
studi
mainli
pediatr
popul
examin
natur
tempor
pattern
bacteri
colon
viral
infect
one
clinic
investig
assess
presenc
densiti
pneumonia
h
influenza
catarrhali
nasopharynx
children
urt
infect
healthi
state
report
proport
children
colon
bacteria
higher
infect
asymptomat
surveil
visit
mean
densiti
bacteri
speci
significantli
higher
visit
viru
detect
interestingli
percentag
colon
children
bacteri
densiti
also
higher
asymptomat
visit
viru
detect
viru
detect
anoth
studi
famili
small
children
use
longitudin
nasal
swab
sampl
demonstr
rhinoviru
infect
associ
increas
acquisit
pneumonia
commun
well
increas
transmiss
pneumonia
within
famili
group
examin
effect
experiment
innocul
hrv
urt
nare
figur
studi
report
signific
chang
total
read
count
main
phyla
eg
actinobacteria
firmicut
proteobacteria
time
nasopharyng
sampl
throat
swab
oropharyng
compart
rhinoviru
infect
associ
strong
trend
toward
transient
increas
rel
abund
h
parainfluenza
neisseria
subflava
weak
trend
toward
increas
aureu
day
abund
bacteria
return
baselin
nasopharyng
sampl
show
complet
opposit
result
decreas
rel
abund
haemophilu
neisseria
spp
increas
normal
nasal
commens
propionibacterium
subject
follow
hrv
infect
differ
staphylococcu
observ
howev
number
subject
small
studi
limit
power
detect
chang
time
nasopharyng
microbiota
composit
shown
alter
influenza
vaccin
figur
administr
live
attenu
influenza
vaccin
laiv
nasal
instil
healthi
children
increas
nasal
colon
densiti
pneumonia
subject
harbor
bacterium
time
vaccin
transient
increas
rate
colon
h
influenza
healthi
adult
volunt
demonstr
intranas
laiv
administr
induc
increas
divers
nasopharyng
microbiom
figur
chang
human
upper
respiratori
tract
microbiom
follow
viral
exposur
given
bacteri
pneumonia
frequent
aris
result
aspir
bacteri
pathogen
potenti
mechan
viral
infect
might
increas
risk
secondari
bacteri
infect
increas
colon
upper
respiratori
tract
bacteri
pathogen
human
subject
live
attenu
influenza
vaccin
laiv
human
rhinoviru
hrv
shown
disrupt
local
host
bacteri
commun
increas
rel
abund
potenti
pathogen
pathobiont
staphylococc
neisseria
speci
major
chang
upper
respiratori
tract
microbiom
highlight
well
rel
abund
staphylococcu
bacteroid
chang
observ
subject
given
salin
nasal
spray
mous
model
bacteri
densiti
nasopharynx
laiv
administr
increas
much
time
compar
influenzana
host
durat
carriag
pneumonia
aureu
also
increas
howev
system
vaccin
also
alter
urt
microbiom
longitudin
studi
healthi
subject
found
signific
associ
presenc
lactobacillu
helveticu
prevotella
melaninogenica
streptococcu
infanti
veillonella
dispar
bacteroid
ovatu
influenzaspecif
iga
antibodi
respons
thu
remark
rel
mild
viral
stimulu
flu
vaccin
lead
detect
chang
urt
microbiom
although
data
still
preliminari
anim
studi
suggest
antivir
immun
activ
contribut
chang
urt
microbiom
facilit
colon
potenti
pathogen
aureu
mous
model
aureu
nasal
colon
absenc
type
ifn
receptor
associ
decreas
persist
bacteria
type
iii
ifn
also
induc
influenza
infect
led
chang
nasal
microbiom
includ
increas
number
cultur
bacteria
increas
upper
respiratori
tract
persist
aureu
well
increas
risk
aureu
pneumonia
observ
fluinfect
wildtyp
mice
compar
mice
lack
type
iii
ifn
receptor
current
howev
unclear
extent
viralinduc
chang
urt
microbiom
alter
subsequ
immun
respons
secondari
bacteri
infect
compar
studi
urt
microbiom
studi
lrt
microbiom
follow
viral
infect
rel
scarc
due
difficulti
obtain
uncontamin
sampl
lung
sampl
conveni
sputum
suffer
oral
contamin
bronchoscop
sampl
invas
expens
obtain
regular
basi
moreov
unclear
whether
outsid
patient
chronic
lung
diseas
eg
copd
lung
microbi
burden
suffici
magnitud
exert
robust
effect
immun
respons
risk
secondari
bacteri
infect
viral
infect
data
mous
model
influenza
infect
seem
indic
flu
infect
modest
effect
bacteri
count
divers
composit
lung
microbiom
subject
chronic
obstruct
pulmonari
diseas
copd
hrv
infect
healthi
individu
increas
bacteri
burden
growth
bacteria
present
baselin
particularli
h
influenza
research
observ
growth
bacteria
seem
aris
exist
commun
pneumonia
intranas
inocul
mice
preinfect
influenza
viru
first
colon
nose
follow
trachea
lung
sever
day
later
purul
inflamm
howev
effect
observ
uninfect
anim
suggest
pneumococc
infect
may
sequenti
develop
urt
lrt
influenza
virusinfect
subject
thu
possibl
individu
influenza
infect
might
develop
chang
lung
microbiom
result
chang
urt
microbi
commun
respiratori
virus
alter
bacteri
commun
urt
also
promot
bacteri
colon
lrt
varieti
mechan
impair
bacteri
clearanc
first
mucu
product
respiratori
tract
increas
facilit
viral
clearanc
infect
howev
excess
mucu
product
lead
airway
obstruct
imped
mucociliari
clearanc
second
viral
infect
also
reduc
ciliari
beat
frequenc
number
ciliat
cell
disrupt
coordin
movement
cilia
imped
repair
respiratori
epitheli
cell
lead
reduc
mucociliari
clearanc
third
respiratori
viral
infect
impair
innat
immun
respons
bacteria
innat
immun
cell
includ
macrophag
neutrophil
recruit
lung
cytokin
chemokin
phagocytosi
bactericid
activ
prior
viral
infect
dysregul
alveolar
macrophag
neutrophil
therebi
inhibit
bactericid
activ
thu
multipl
aspect
pulmonari
host
defens
impair
would
entir
surpris
subset
influenza
infect
patient
develop
secondari
bacteri
pneumonia
result
unabl
clear
aspir
pathobiont
urt
addit
enabl
us
determin
present
state
health
largescal
sequencingbas
microbiom
analys
also
reveal
present
diseas
long
appreci
mechan
evolv
bacteria
confer
competit
advantag
permit
surviv
otherwis
inhospit
host
environ
howev
interspeci
competit
also
maintain
homeostasi
microbi
commun
either
abil
captur
scare
resourc
eg
iron
target
kill
bacteria
eg
bacteriocin
prevent
one
microb
domin
commun
thu
possibl
immun
respons
incit
acut
viral
infect
chang
host
epitheli
surfac
caus
viru
viru
might
lead
elimin
host
commens
respons
keep
pathobiont
check
exampl
epidermidi
propionibacterium
acn
abund
nare
shown
neg
associ
aureu
carriag
understand
interact
may
creat
new
avenu
therapeut
intervent
aim
reduc
colon
pathogen
bacteria
influenza
epidem
pandem
one
group
commens
examin
role
inhibit
nasal
carriag
aureu
pneumonia
corynebacterium
spp
earli
studi
japan
report
effect
introduc
corynebacterium
strain
nare
healthi
adult
hospit
worker
persist
carrier
aureu
success
erad
subject
mechan
appear
bacteriocinindepend
comparison
epidermidi
implant
effect
whether
epidermidi
strain
use
express
serin
proteas
esp
inhibit
biofilm
format
aureu
nasal
colon
unknown
subsequ
studi
anoth
group
report
c
pseudodiphtheriticum
inhibit
aureu
growth
wherea
c
accolen
aureu
appear
support
growth
convers
investig
observ
corynebacterium
spp
enrich
children
nasal
colon
pneumococcu
demonstr
c
accolen
inhibit
pneumonia
growth
vitro
express
lipas
releas
free
fatti
acid
skin
surfac
triacylglycerol
inhibit
pneumococc
growth
thu
painstak
identif
mechanist
interrog
interspeci
competit
commens
might
lead
novel
insight
viral
infect
might
confer
competit
advantag
pathobiont
exploit
natur
strategi
employ
commens
restor
homeostasi
host
microbi
nich
interestingli
recent
preclin
studi
use
murin
model
rsv
pneumonia
superinfect
employ
nasal
prime
c
pseudodiphtheriticum
strain
augment
host
defens
viral
infect
enhanc
clearanc
secondari
bacteri
challeng
reduc
lung
injuri
measur
final
direct
effect
infect
viru
bacteria
compris
microbiom
may
facilit
transit
pathobiont
pathogen
metagenom
analysi
show
airway
microbiota
enrich
gene
associ
cell
motil
transcript
regul
metabol
respons
chemotaxi
compar
bacteria
noninfect
patient
data
impli
influenza
infect
perturb
respiratori
microbiom
lead
product
secondari
metabolit
includ
immunemodul
molecul
virus
also
found
impair
bacteri
biofilm
format
disrupt
exist
biofilm
influenza
shown
affect
pneumonia
transcriptom
term
downregul
express
gene
associ
colon
state
upregul
bacteriocin
thu
direct
effect
virus
bacteri
transcript
pattern
might
mechan
colon
bacteria
acquir
invas
potenti
therebi
lead
bacteri
superinfect
sever
area
must
address
futur
respiratori
microbiom
research
first
necessari
standard
protocol
use
analyz
respiratori
microbiom
includ
sampl
process
bioinformat
methodolog
exampl
sputum
may
appropri
materi
investig
respiratori
diseas
sinc
contain
compon
lrt
obtain
easili
howev
reliabl
inform
lrt
requir
invas
sampl
bal
protect
specimen
brush
frontier
immunolog
wwwfrontiersinorg
bronchiallung
biopsi
second
studi
limit
experi
conduct
anim
model
even
human
studi
analys
perform
small
number
patient
describ
bacteri
commun
urt
role
microbi
commun
outsid
lung
includ
gut
sinu
skin
consid
context
airway
diseas
third
studi
microbiom
focus
bacteri
compon
larg
omit
fungi
virus
role
virusesinclud
vast
number
phage
infect
bacteriaand
fungi
respiratori
diseas
examin
rrna
gene
analys
studi
describ
composit
role
respiratori
virom
due
difficulti
comprehens
analys
virus
fourth
suffici
studi
microbi
commun
base
speci
composit
function
character
transcriptom
proteasom
analys
necessari
understand
mechanist
role
microbiom
outcom
infect
final
mucos
microbiom
manipul
vaccin
antibiot
probiot
gastrointestin
respiratori
tract
nich
repres
novel
approach
prevent
treatment
manag
acut
chronic
lung
diseas
howev
given
antibiot
therapi
could
affect
commens
bacteria
hasten
emerg
drugresist
bacteria
research
need
longterm
effect
therapi
anim
model
develop
studi
influenc
urt
lrt
microbiom
immun
respons
respiratori
viral
infect
possibl
consid
clinic
applic
microbiom
modul
strategi
respiratori
viral
infect
initi
cascad
host
immun
respons
alter
microbi
growth
condit
urt
lrt
gut
supplement
tabl
activ
influenzainduc
antivir
interferon
pathway
lead
inadequ
innat
immun
cell
respons
host
defens
secondari
bacteri
infect
result
prolifer
potenti
pathogen
bacteri
speci
concomit
chang
gut
microbiom
caus
initi
viral
infect
may
also
alter
immun
cell
prime
secondari
bacteri
challeng
although
examin
date
although
pictur
incomplet
recent
microbiom
literatur
provid
addit
insight
pathogenesi
dysregul
immun
respons
follow
acut
viral
infect
may
promot
develop
secondari
bacteri
pneumonia
figur
clarifi
differ
dynam
respiratori
microbiota
healthi
subject
chronic
lung
diseas
acut
respiratori
viral
infect
elucid
pathogenesi
viralbacteri
interact
provid
basi
develop
novel
approach
prevent
treatment
manag
acut
respiratori
infect
exacerb
chronic
lung
diseas
sh
jd
cowrot
manuscript
sh
jd
mp
design
figur
tabl
kc
mp
edit
provid
critic
revis
manuscript
author
approv
final
version
agre
account
content
manuscript
jd
support
research
grant
nation
institut
health
grant
view
express
articl
author
necessarili
reflect
posit
polici
depart
veteran
affair
us
govern
thank
cat
meyer
assist
figur
supplementari
materi
articl
found
onlin
http
supplementarymateri
